Jump to Main Contents
Institute for Cancer Control

Home > Divisions & Departments > Division of Supportive Care, Survivorship and Translational Research > Publications

Publications

2022

  1. Kurisu K, Hashimoto M, Ishizawa T, Shibayama O, Inada S, Fujisawa D, Inoguchi　H, Shimoda H, Inoue S, Ogawa A, Akechi T, Shimizu K, Uchitomi Y, Matsuyama Y,　Yoshiuchi K. Development of computer adaptive testing for measuring depression　in patients with cancer. Sci Rep. 2022 May 17;12(1):8247. [35581321]
  2. Saito J, Odawara M, Takahashi H, Fujimori M, Yaguchi-Saito A, Inoue M, Uchitomi Y, Shimazu T*. Barriers and facilitative factors in the implementation of workplace health promotion activities in small and medium-sized enterprises: a qualitative study. Implement Sci Commun. 2022 Mar 2;3(1):23. [35236511]
  3. Akechi T, Kubota Y, Ohtake Y, Setou N, Fujimori M, Takeuchi E, Kurata A, Okamura M, Hasuo H, Sakamoto R, Miyamoto S, Asai M, Shinozaki K, Onishi H, Shinomiya T, Okuyama T, Sakaguchi Y, Matsuoka H. Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer. Jpn J Clin Oncol. 2022 Mar 6:hyac025. [35253040]
  4. Okamura M, Fujimori M*, Goto S, Obama K, Kadowaki M, Sato A, Hirayama T, Uchitomi Y. Prevalence and associated factors of psychological distress among young adult cancer patients in Japan. Palliat Support Care. 2022 Feb 28:1-7. [35225198]
  5. Matsuoka A*, Fujimori M. Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer. JAMA Oncol. 2022 Apr 1;8(4):1. [35201282]
  6. Sato A, Fujimori M*, Shirai Y, Umezawa S, Mori M, Jinno S, Umehashi M, Okamura M, Okusaka T, Majima Y, Miyake S, Uchitomi Y. Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study - ERRATUM. Palliat Support Care. 2022 Feb 9:1-3. [35135645]
  7. Matsumoto Y, Umemura S, Okizaki A, Fujisawa D, Kobayashi N, Tanaka Y, Sasaki C, Shimizu K, Ogawa A, Kinoshita H, Uchitomi Y, Yoshiuchi K, Matsuyama Y, Morita T, Goto K, Ohe Y. Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme. Jpn J Clin Oncol. 2022 Apr 6;52(4):375-382. [35079813]

2021

  1. Etoh T, Fujiwara M, Yamada Y, Wada R, Higuchi Y, Inoue S, Kodama M, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Kakeda K, Shimazu T, Nakaya N, Tabata M, Uchitomi Y, Yamada N, Inagaki M. Cancer care for people with mental disorders: A qualitative survey among cancer care and psychiatric care professionals in Japan. Psychooncology. 2021 Dec;30(12):2060-2066. [34435715]
  2. Inoue K, Kawashima Y, Noguchi H, Fujimori M, Akechi T, Kawanishi C, Uchitomi Y, Matsuoka YJ*. Attitude to suicide prevention and suicide intervention skills among oncology professionals: An online cross-sectional survey in Japan. Psychiatry Clin Neurosci. 2021 Dec;75(12):401-402. [34435416]
  3. Fujiwara M, Yamada Y, Shimazu T, Kodama M, So R, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Takahashi H, Nakaya N, Kakeda K, Miyaji T, Hinotsu S, Harada K, Okada H, Uchitomi Y, Yamada N, Inagaki M. Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial. Acta Psychiatr Scand. 2021 Jul 9. [34242396]
  4. Okamura M, Fujimori M*, Hata K, Mori M, Mack JW, Prigerson HG, Uchitomi Y. Validity and reliability of the Japanese version of the Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE) questionnaire. Palliat Support Care. 2021 Jun 30:1-7. [34190680]
  5. Wada R, Fujiwara M, Yamada Y, Nakaya N, Fujimori M, So R, Kodama M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Validity and Reliability of the Japanese Version of the 12-item Self-administered World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in Patients with Schizophrenia. Acta Med Okayama. 2021 Jun;75(3):315-322 .[34176935]
  6. Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, Bhandari PM, Negeri Z, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) HADS Group. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021 May 10;373:n972. [33972268]
  7. Harashima S, Fujimori M*, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ. Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902). Jpn J Clin Oncol 2021 Feb 3;hyab001 [33529336]
  1. Chen SH, Chen SY, Yang SC, Chien RN, Chen SH, Chu TP, Fujimori M, Tang WR. Effectiveness of communication skill training on cancer truth-telling for advanced practice nurses in Taiwan: A pilot study. Psychooncology. 2021 May;30(5):765-772. doi: 10.1002/pon.5629. Epub 2021 Jan 25. [33427382]
  2. Okamura M, Fujimori M*, Sato A, Uchitomi Y. Unmet supportive care needs and associated factors among young adult cancer patients in Japan. BMC Cancer. 2021 Jan 5;21(1):17. doi: 10.1186/s12885-020-07721-4. [33402126]
  3. Brehaut E, Neupane D, Levis B, Wu Y, Sun Y, Krishnan A, He C, Bhandari PM, Negeri Z, Riehm KE, Rice DB, Azar M, Yan XW, Imran M, Chiovitti MJ, Saadat N, Cuijpers P, Ioannidis JPA, Markham S, Patten SB, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Boruff JT, Kloda LA, Beraldi A, Braeken APBM, Carter G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, De Souza J, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Goebel S, Jetté N, Julião M, Keller M, Kjærgaard M, Love AW, Löwe B, Martin-Santos R, Michopoulos I, Navines R, O'Rourke SJ, Öztürk A, Pintor L, Ponsford JL, Rooney AG, Sánchez-González R, Schwarzbold ML, Sharpe M, Simard S, Singer S, Stone J, Tung KY, Turner A, Walker J, Walterfang M, White J, Benedetti A, Thombs BD. Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis. J Psychosom Res. 2020 Dec;139:110256. [33069051]
  4. Fujimori M*, Sato A, Jinno S, Okusaka T, Yamaguchi T, Ikeda M, Ueno M, Ozaka M, Takayama Y, Miyaji T, Majima Y, Uchitomi Y. Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial. BMJ Open. 2020 Sep 23;10(9):e036745. [32967874]
  5. Wu Y, Levis B, Ioannidis JPA, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration. Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. Psychother Psychosom. 2021;90(1):28-40. [32814337]
  6. Wada S, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Sato T, Shimada K, Yoshimoto S, Daiko H, Kanemitsu Y, Kawai A, Kato T, Fujimoto H, Shimizu K*: Yokukansan for treatment of preoperative anxiety and prevention of postoperative delirium in cancer patients undergoing highly invasive surgery. J-SUPPORT 1605 (ProD Study): A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 2021 Jan;61(1):71-80. [32800969]

2020

  1. Fujisawa D, Umezawa S, Fujimori M, Miyashita M. Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors. Jpn J Clin Oncol. 2020 Oct 22;50(11):1325-1329. [32776092]
  2. Chen SY, Fujimori M, Wang HM, Tang WR. Gender Differences in Cancer Patients' Preferences for Truth-Telling in Taiwan. Cancer Nurs. 2020 Jul 8. [32649335]
  3. Higuchi Y, Fujiwara M, Nakaya N, Fujimori M, Yamada Y, Wada R, Etoh T, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Trends in smoking rates among individuals with serious psychological distress: Analysis of data from a Japanese national survey, 2007-2016. Psychiatry Res. 2020 Sep;291:113225. [32599444]
  4. Fuijmori M*, Harashima S. Risk of suicide among adolescents and young adults with cancer and a need for targeted interventions. Ann Transl Med 2020 Apr;8(7):428 [32395472]
  1. Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, Bhandari PM, Imran M, Chiovitti MJ, Saadat N, Boruff JT, Cuijpers P, Gilbody S, McMillan D, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Al-Adawi S, Beraldi A, Braeken APBM, Büel-Drabe N, Bunevicius A, Carter G, Chen CK, Cheung G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, Dabscheck E, Daray FM, Douven E, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Gandy M, Goebel S, Grassi L, Härter M, Jenewein J, Jetté N, Julião M, Kim JM, Kim SW, Kjærgaard M, Köhler S, Loosman WL, Löwe B, Martin-Santos R, Massardo L, Matsuoka Y, Mehnert A, Michopoulos I, Misery L, Navines R, O'Donnell ML, Öztürk A, Peceliuniene J, Pintor L, Ponsford JL, Quinn TJ, Reme SE, Reuter K, Rooney AG, Sánchez-González R, Schwarzbold ML, Senturk Cankorur V, Shaaban J, Sharpe L, Sharpe M, Simard S, Singer S, Stafford L, Stone J, Sultan S, Teixeira AL, Tiringer I, Turner A, Walker J, Walterfang M, Wang LJ, White J, Wong DK, Benedetti A, Thombs BD. Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. J Psychosom Res. 2020 Feb;129:109892. [31911325]
  2. Wada S, Sadahiro R, Matsuoka Y, Uchitomi Y, Shimizu K*. The association between postoperative recovery and psychosocial factors in cancer patients. J Surgery 2020;8(1):9-15 [10.11648/j.js.20200801.13]

2019

  1. Fujiwara M, Inagaki M*, Shimazu T, Kodama M, So R, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Takahashi H, Nakaya N, Kakeda K, Miyaji T, Hinotsu S, Harada K, Okada H, Uchitomi Y, Yamada N. A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study. BMJ Open 2019 Nov 2;9(11):e03295 [31678957]
  2. Higuchi Y, Fujiwara M, Nakaya N, U, Hayashibara C, So R, Shinkawa I, Sato K, Yada Y, Kodama M, Takenaka H, Kishi Y, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan.　BMC Psychiatry. 2019 Nov 21;19(1):367. [31752799]
  3. Mori M*, Fujimori M*, van Vliet LM, Yamaguchi T, Shimizu C, Kinoshita T, Morishita-Kawahara M, Inoue A, Inoguchi H, Matsuoka Y, Bensing JM, Bruera E, Morita T, Uchitomi Y. Explicit prognostic disclosure to Asian women with breast cancer: a randomized script video-vignette study (J-SUPPORT1601). Cancer 2019 Oct 1;125(19):3320-3329. [31206639]
  4. Sadahiro R, Sawada N*, Matsuoka YJ*, Mimura M, Nozaki S, Ryo S, Goto A, Tsugane S. Midlife cancer/diabetes and risk of dementia and MCI: a population-based prospective cohort study in Japan. Psychiatry Clin Neurosci 2019 Sep;73(9):597-599. [31226234]
  5. Mori M*, Fujimori M, Ishiki H, Nishi T, Hamano J, Otani H, Uneno Y, Oba A, Morita T, Uchitomi Y. Adding a Wider Range and "Hope for the Best, and Prepare for the Worst" Statement: Preferences of Patients with Cancer for Prognostic Communication. Oncologist. 2019 Sep;24(9):e943-e952. [30782978]
  6. Harashima S, Fujimori M*, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ. Suicide, other externally caused injuries, and cardiovascular death following a cancer diagnosis: study protocol for a nationwide population-based study in Japan. BMJ Open 2019 Jul 4;9(7):e030681 [31278108]
  7. Mori M*, Fujimori M, Ishiki H, Nishi T, Hamano J, Otani H, Uneno Y, Oba A, Morita T, Uchitomi Y：The effects of adding reassurance statements: Cancer patients' preferences for phrases in end-of-life discussions. J Pain Symptom Manage 2019 Jun;57(6):1121-1129. [30818028]
  8. Wada S, Sadahiro R, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Shimizu K*: Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery: a randomized, double-blind, placebo-controlled trial. J-SUPPORT1605 (ProD Study). Trials 2019 Feb 8;20(1): 110 [30736826]
  9. Wada S, Sadahiro R, Inoguchi H, Sadahiro R, Matsuoka YJ, Uchitomi Y, Sato T, Shimada K, Yoshimoto S, Daiko H, Shimizu K*. Preoperative anxiety as a predictor of delirium in cancer patients: a prospective observational cohort study. World J Surgery 2019 Jan;43(1): 134-142 [30128769]
  10. Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, Akechi T, Wada N, Imoto S, Murakami K, Ogawa A, Uchitomi Y*: Longterm influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy. Int J Clin Oncol 2019 Jan; 24(1): 68-77. [30168090]

2018

  1. Yamada Y, Fujimori M*, Shirai Y, Ninomiya H, Oka T, Uchitomi Y: Changes in Physicians' Intrapersonal Empathy After a Communication Skills Training in Japan. Acad Med. 2018 Dec;93(12):1821-1826 [30134272]
  1. Tagami K, Okizaki A, Miura T, Watanabe YS, Matsumoto Y, Morita T, Fujimori M, Kinoshita H. Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain. J Palliat Med. 2018 Nov;21(11):1636-1640.[29975582]
  2. Hashimoto H, Abe M, Yanai T, Yamaguchi T, Zenda S, Uchitomi Y, Fukuda H, Mori M, Iwasa S, Yamamoto N, Ohe Y. Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy. Jpn J Clin Oncol. 2018 Oct 1;48(10):950-952. [30124989]
  3. Zenda S*, Yamaguchi T, Yokota T, Miyaji T, Mashiko T, Tanaka M, Yonemura M, Takeno M, Okano T, Kawasaki T, Nakamori Y, Ishii S, Shimada S, Uchitomi Y. Topical Steroid versus Placebo for the Prevention of Radiation Dermatitis in Head and Neck Cancer Patients receiving Chemoradiotherapy: The Study Protocol of J-SUPPORT 1602 (TOPICS Study), a Randomized Double-blinded Phase 3 Trial. BMC Cancer. 2018 Sep 6;18(1):873. [30189840]
  4. Fujiwara M, Inagaki M*, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N.: Smoking among adults with serious psychological distress: analysis of anonymized data from a national cross-sectional survey in Japan. J Affective Disorders 2018 Jul 3;239:131-137 [30005326]
  5. Watanabe Y, Miura T, Okizaki A, Tagami K, Matsumoto Y, Fujimori M, Morita M, Kinoshita H: Comparison of indicators for achievement of pain control with personalized pain goal in a comprehensive cancer center. J Pain Symptom Manage. 2018 Apr;55(4):1159-1164. [29248568]
  6. Inagaki M*, Fujiwara M, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, Yamada N: Low Cancer Screening Rates among Japanese People with Schizophrenia: A Cross-Sectional Study. Tohoku J Experiment Med, 2018 Mar; 244(3): 209-218 [29540627]
  7. Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N: Association between serious psychological distress and non-participation in cancer screening, and the modifying effect of socioeconomic status: analysis of anonymized data from a national cross-sectional survey in Japan. Cancer. 2018 Feb 1;124(3):555-562. [29076156]
  8. Mori M, Fujimori M, Hamano J, Shirado A, Morita T. Which physicians’ behaviors on death pronouncement affect family-perceived physician compassion? A randomized, scripted, video-vignette study. J Pain Symptom Manage. 2018 Feb;55(2):189-197 [28887269]
  9. Hayashibara C, Inagaki M, Fujimori M, Higuchi Y, Fujiwara M, Terada S, Okamura H, Uchitomi Y, Yamada N.　Confidence in communicating with patients with cancer mediates the relationship between rehabilitation therapists' autistic-like traits and perceived difficulty in communication. Palliat Support Care. 2018 Jan 21;1-9. [29352834]

2017

  1. Fujiwara M, Inagaki M*, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, Yamada N. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017 Dec;71(12):813-825. [28875514]
  2. Miyaji T, Iioka Y, Kuroda Y, Yamamoto D, Iwase S, Goto Y, Tsuboi M, Odagiri H, Tsubota Y, Kawaguchi T, Sakata N, Basch E, Yamaguchi T: Japanese translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Patient Rep Outcomes 2017;1(1):8. [29757296]
  3. Wada S, Inoguchi H, Hirayama T, Matsuoka YJ, Uchitomi Y, Ochiai H, Tsukamoto S, Shida D, Kanemitsu Y, Shimizu K*: Yokukansan for the Treatment of Preoperative Anxiety and Postoperative Delirium in Colorectal Cancer Patients: A Retrospective Study. Japanese Jpn J Clin Oncology 2017 Sep 1;47(9): 844-848 [28591818]

.

Division of Health Care Research

2021

  1. Cheng YS, Tseng PT, Wu MK, Tu YK, Wu YC, Li DJ, Chen TY, Su KP, Stubbs B, Carvalho AF, Lin PY,  Matsuoka YJ, Chen YW, Sun CK*, Shiue YL*. Pharmacologic and hormonal treatments for menopausal sleep disturbances: Anetwork meta-analysis of 43 randomized controlled trials and 32,271 menopausal women. Sleep Medicine Reviews 2021 Mar 11;57:101469 [33836486]
  2. Hamazaki K, Matsuoka YJ*, Yamaji T, Sawada N*, Mimura M, Nozaki S, Shikimoto R, Tsugane S. Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective Study. Scientific Reports 2021 February 17;11(1): 4003 [33597590]
  3. Tsuji K*, Matsuoka YJ, Ochi E*: High-intensity interval training in breast cancer survivors: a systematic review. BMC Cancer 2021 Feb 22;21(1):184 [33618699]
  4. Nozaki S*, Sawada N*, Matsuoka YJ, Shikimoto R, Mimura M, Tsugane S. Association between dietary fish and PUFA intake in midlife and dementia in later life: the JPHC Saku Mental Health Study. J Alzheimers Dis 2021;79(3):1091-1104 [33386799]
  5. Narisawa T, Nishi D, Okubo R, Noguchi H, Yamashita A, Hamazaki K, Matsuoka YJ*. Impact of peritraumatic distress on posttraumatic stress disorder symptoms at 6 months after acute coronary syndrome: a prospective cohort study. European J Psychotraumatology 2021 Jan 13;12(1): 1854511[33505638]
  6. Huang KY, Tseng PT, Wu YC, Tu YK, Stubbs B, Su KP, Matsuoka Y, Hsu CW, Lin YW, Chen YW, Lin PY*: Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials. Scientific Reports 2021 Jan 11, 11,452 [33432057]

2020

  1. Tseng PT, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Stubbs B, Carvalho AF, Matsuoka YJ, Li DJ, Liang CS, Hsum CW, Chen YW, Shiue YL*: The association between melatonin and episodic migraine: a pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. J Pineal Res 2020 Sep;69(2):e12663 [32347977]
  2. Morishima T*, Tsuchiya Y, Ueda H, Tsuji K, Ochi E: Sitting-induced Endothelial Dysfunction Is Prevented in Endurance-trained Individuals. Medicine & Science in Sports & Exercise 2020 Aug;52(8):1770-1775 [32079922]
  3. Hirano T, Motohashi T, Okumura K, Takajo K, Kuroki T, Ichikawa D, Matsuoka Y, Ochi E, Ueno T*: Data validation and verification using blockchain in a clinical trial for breast cancer. J Med Internet Res 2020 June 2;22(6):e18938 [32340974]
  4. Matsuoka YJ*, Okubo R, Shimizu Y, Tsuji K, Narisawa T, Sasaki J, Sasai H, Akashi-Tanaka S, Hamaguchi T, Iwasa T, Iwata S, Kato T, Kurotani K, Maruyama D, Mori A, Ogawa A, Sakurai N, Shimazu T, Shimizu C, Tabuchi T, Takahashi M, Takano T, Tatematsu N, Uchitomi Y, Watanabe C, Fukui T. Developing the structure of Japan’s cancer survivorship guidelines using an expert panel and modified Delphi method. J Cancer Survivorship 2020 Jun;14(3):273-283 [31811478]
  5. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP*: A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. J Affective Disorders 2020 March;265:233-238 [32090746]
  6. van der Mei WF, Barbano AC*, Ratanatharathorn A, Bryant RA, Delahanty DL, deRoon-Cassini TA, Lai BS, Lowe SR, Matsuoka YJ, Olff M, Qi W, Schnyder U, Seedat S, Kessler RC, Koenen KC, Shalev AY on behalf of the International Consortium to Predict PTSD. Evaluating a Screener to Quantify PTSD Risk Using Emergency Care Information: A Proof of Concept Study. BMC Emergency Medicine 2020 Mar 2;20(1):16 [32122334]
  7. Okubo R, Kinoshita T, Katsumata N, Uezono Y, Xiao J, Matsuoka YJ*: Impact of chemotherapy on the association between fear of cancer recurrence and gut microbiota in breast cancer survivors. Brain Behav Immunity 2020 Mar;85:186-191 [30818031]
  8. Lowe SR*, Ratanatharathorn A, Lai BS, van der Mei W, Barbano AC, Bryant RA, Delahanty DL, Matsuoka YJ, Olff M, Schnyder U, Laska E, Koenen KC, Shalev AY, Kessler RC on behalf of the ICPP.  Posttraumatic Stress Disorder Symptom Trajectories Within the First Year Following Emergency Department Admissions: Pooled Results from the International Consortium to Predict PTSD. Psychological Medicine 2020 Feb 3;1-11. [32008580]
  9. Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, Bhandari PM, Imran M, Chiovitti MJ, Saadat N, Boruff JT, Cuijpers P, Gilbody S, McMillan D, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Al-Adawi S, Beraldi A, Braeken APBM, Büel-Drabe N, Bunevicius A, Carter G, Chen CK, Cheung G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, Dabscheck E, Daray FM, Douven E, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Gandy M, Goebel S, Grassi L, Härter M, Jenewein J, Jetté N, Julião M, Kim JM, Kim SW, Kjærgaard M, Köhler S, Loosman WL, Löwe B, Martin-Santos R, Massardo L, Matsuoka Y, Mehnert A, Michopoulos I, Misery L, Navines R, O'Donnell ML, Öztürk A, Peceliuniene J, Pintor L, Ponsford JL, Quinn TJ, Reme SE, Reuter K, Rooney AG, Sánchez-González R, Schwarzbold ML, Senturk Cankorur V, Shaaban J, Sharpe L, Sharpe M, Simard S, Singer S, Stafford L, Stone J, Sultan S, Teixeira AL, Tiringer I, Turner A, Walker J, Walterfang M, Wang LJ, White J, Wong DK, Benedetti A, Thombs BD*. Probability of major depression diagnostic classification based on the DCID, CIDI, and MINI diagnostic interviews controlling for hospital anxiety and depression scale – depression subscale scores: An individual participants data meta-analysis of 73 primary studies. J Psychosom Res 2020 Feb;129:109892 [31911325]
  10. Shimizu Y, Tsuji K, Ochi E, Arai H, Okubo R, Kuchiba A, Shimazu T, Sakurai N, Narisawa T, Ueno T, Iwata H, Matsuoka YJ*. Study protocol for a nationwide questionnaire survey of physical activity among breast cancer survivors in Japan. BMJ Open 2020;10:e032871 [31964669]

2019

  1. Horigome A, Okubo R, Hamazaki K, Kinoshita T, Katsumata N, Uezono Y, Xiao JZ*, Matsuoka YJ*. Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors. Beneficial Microbes 2019 Oct 14;10(7):751-758. [31965846]
  2. Noguchi H, Okubo R, Hamazaki K, Yamashita A, Narisawa T, Matsuoka YJ*: Serum polyunsaturated fatty acids and risk of psychiatric disorder at 6 months after acute coronary syndrome: A prospective cohort study. Prostaglandins Leukot Essent Fatty Acids 2019 Oct;149:18-23. [31421523]
  3. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP*: International Society for Nutritional Psychiatric Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychother Psychosom 2019 Sep 3;88(5):263-273 [31480057]
  4. Okubo R, Wada S, Shimizu Y, Tsuji K, Hanai A, Imai K, Uchitomi Y, Fujiwara Y, Tsugane S, Matsuoka YJ*. Expectations of and recommendations for a cancer survivorship guideline in Japan: a literature review of guidelines for cancer survivorship. Jpn J Clinical Oncology 2019 Sep 1;49(9):812-822. [31095338]
  5. Tsuji K, Ochi E, Okubo R, Shimizu Y, Kuchiba A, Ueno T, Shimazu T, Kinoshita T, Sakurai N, Matsuoka YJ*. Effect of home-based high intensity intermittent training and behavioral modification using information and communication technology on cardiorespiratory fitness and exercise habits among sedentary breast cancer survivors: habit-B study protocol for a randomized controlled trial. BMJ Open 2019 Aug 22;9(8):e030911 [31444192]
  6. Barbano AC*, van der Mei WF, deRoon-Cassini TA, Grauer E, Lowe SR, Matsuoka YJ, O’Donnell M, Olff M, Qi W, Ratanatharathorn A, Schnyder U, Seedat S, Kessler RC, Koenen KC, Shalev AY, On behalf of the International Consortium to Prevent PTSD: Differentiating PTSD from Anxiety and Depression: Lessons from the ICD-11 PTSD Diagnostic Criteria. Depression and Anxiety 2019 Jun;36(6):490-498 [30681235]
  7. Watanabe N*, Horikoshi M, Shinmei I, Oe Y, Narisawa T, Kumachi M, Matsuoka Y, Hamazaki K, Furukawa TA. Brief mindfulness-based stress management program for a better mental state in working populations - Happy Nurse Project: a randomized controlled trial. J Affective Disorders 15 May 2019; 251: 186-194 [30927579]
  8. Okubo R, Matsuoka YJ*, Sawada N*, Mimura M, Kurotani K, Nozaki S, Shikimoto R, Tsugane S. Diet quality and depression risk in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective Study. Scientific Reports 9,7150, May 9, 2019 [31073185]
  9. Wu YC, Tseng PT, Tu YK, Hsu CY, Liang CS, Yeh TC, Chen TY, Chu CS, Matsuoka YJ, Stubbs B, Carvalho AF, Wada S, Lin PY, Chen YW, Su KP*: Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis. JAMA Psychiatry 2019 May 1;76(5):526-535 [30810723]
  10. Satogami K, Tseng PT, Su KP*, Takahashi S, Ukai S, Li DJ, Chen TY, Lin PY, Chen YW, Matsuoka YJ: Relationship between polyunsaturated fatty acid and eating disorders: systematic review and meta-analysis. Prostaglandins Leukot Essent Fatty Acids. 2019 Mar;142: 11-19 [30773209]
  11. Nishi D*, Su KP, Usuda K, Chang JPC, Hamazaki K, Ishima T, Sano Y, Ito H, Isaka K, Tachibana Y, Tanigaki S, Suzuki T, Hashimoto K, Matsuoka YJ. Plasma estradiol levels and antidepressant effects of omega 3 fatty acids in pregnant women. Brain Behavior and Immunity 2020 Mar;85: 29-34 [30776476]
  12. Shalev A*, Gevonden M, Ratanatharathorn A, Laska E, van der Mei WF, Qi W, Lowe S, Lai BS, Bryant RA, Delahanty D, Matsuoka YJ, Olff M, Schnyder U, Seedat S, deRoon-Cassini TA, Kessler RC, Koenen KC, on behalf of the International Consortium to Predict PTSD. Estimating the risk of PTSD in recent trauma survivors: results of the International Consortium to Predict PTSD (ICPP). World Psychiatry 2019 Feb;18(1): 77-87 [30600620]
  13. Okubo R, Koga M, Katsumata N, Odamaki T, Matsuyama S, Oka M, Narita H, Hashimoto N, Kusumi I, Xiao J, Matsuoka YJ*: Effect of Bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. J Affective Disorders 2019; 245: 377-385 15 February [30423465]
  14. Okubo R, Noguchi H, Narisawa T, Hamazaki K, Sekiguchi M, Kinoshita T, Katsumata N, Xiao JZ, Matsuoka YJ*: Fear of cancer recurrence among breast cancer survivors could be controlled by prudent dietary modification with polyunsaturated fatty acids. J Affective Disorders 245: 1114-1118, 15 February, 2019 [30699854]
  15. Nishi D*, Su KP*, Usuda K, Chang JPC, Chiang YJJ, Guu TW, Okazaki E, Hamazaki K, Susukida R, Nakaya N, Sone T, Sano Y, Ito H, Isaka K, Tachibana Y, Tanigaki S, Suzuki T, Hashimoto K, Hamazaki T, Matsuoka YJ: The efficacy of omega 3 fatty acids for depressive symptoms among pregnant women in Japan and Taiwan: A randomized, double-blind, placebo-controlled trial (SYNCHRO; NCT01948596). Psychother Psychosom 2019;88(2): 122-124. [30540990]
  16. Yoshikawa E, Nishi D*, Kashimura M, Matsuoka YJ: Role of resilience for the association between trait hostility and depressive symptoms in Japanese company workers. Curr Psychol 07 February 2019 [https://doi.org/10.1007/s12144-019-0166-y]
  17. Barbano AC*, van der Mei WF, Bryant RA, Delahany DL, deRoon-Cassini TA, Matsuoka YJ, Olff M, Qi W, Ratanatharathorn A, Schnyder U, Seedat S, Kessler RC, Koenen KC and Shalev AY: Clinical implications of the proposed ICD-11 PTSD criteria. Psychological Medicine. 2019 Feb;49(3): 483-490 [29754591]

2018

  1. Kurosawa K, Terao T*, Kanehisa M, Shiotsuki I, Ishii N, Takenaka R, Sakamoto T, Matsukawa T, Ando S, Nishida A, Matsuoka Y: Naturally absorbed polyunsaturated fatty acids, lithium, and suicide-related behaviors: a case-controlled study. J Affective Disorders 2018 Dec1 ; 241:200-205 [30130685]
  2. Matsumura K*, Noguchi H, Rolfe P, Yamakoshi T, Matsuoka Y: Differential effect of two mental stress tasks on arterial stiffness. Japanese Psychological Research 23 October 2019;61(4):249-261 [http://doi.org/10.1111/jpr.12235]
  3. Su KP, Tseng PT, Lin PY, Okubo R, Chen TY, Chen YW, Matsuoka YJ*: Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms. A Systematic Review and Meta-analysis. JAMA Network Open 2018 Sep 7;1(5):e182327. [30646157]
  4. Watanabe N*, Matsuoka Y, Kumachi M, Hamazaki K, Horikoshi M, Furukawa TA: Omega-3 fatty acids for a better mental state in working populations - Happy Nurse Project: a 52-week randomized controlled trial. J Psychiatric Research 2018; 102: 72-80 [29627596]
  5. Wei Qi*, Ratanatharathorn A, Gevonden M, Bryant R, Delahanty D, Matsuoka Y, Olff M, deRoon-Cassini T, Schnyder U, Seedat S, Laska E, Kessler R, Koenen K, Shalev A on behalf of the ICPP: Application of Data Pooling to Longitudinal Studies of Early PTSD: The International Consortium to Predict PTSD (ICPP) Project. Eur J Psychotraumatol 2018 Jun 14;9(1):1476442 [29938009]
  6. Okubo R, Chen C, Sekiguchi M, Hamazaki K, Matsuoka YJ*: Mechanisms underlying the effects of n-3 polyunsaturated fatty acids on fear memory processing and their hypothetical effects on fear of cancer recurrence in cancer survivors. Prostaglandins Leukot Essent Fatty Acids 2018 Apr;131:14-23 [29628046]
  7. Furuno T, Nakagawa M, Hino K, Shirakawa O, Yamada T, Kawashima Y, Matsuoka Y, Shirakawa O, Ishizuka N, Yonemoto N, Kawanishi C, Hirayasu Y: Effectiveness of assertive case management on repeat self-harm in patients admitted for suicide attempt: findings from ACTION-J study. J Affective Disorders 2018 Jan 1;225:460-465. [28863298]

2017

  1. Noguchi H, Nishi D, Matsumura K, Hamazaki K, Hamazaki T, Matsuoka Y: Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: A randomized, placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids. 2017 Dec;127:1-5. [29156152]
  2. Matsumura K, Noguchi H, Nishi D, Hamazaki K, Hamazaki T, Matsuoka YJ: Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: a randomized, double-blind, placebo-controlled trial. J Affective Disorders 2017 December 15;224: 27-31 [27287561]
  3. Okubo R, Inoue T, Hashimoto N, Suzukawa A, Tanabe H, Oka M, Narita H, Ito K, Kako Y, Kusumi I: The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia. Psychiatry Res. 2017 Nov;257:126-131 [28755602]
  4. Matsuoka YJ, Sawada N, Mimura M, Shikimoto R, Nozaki S, Hamazaki K, Uchitomi Y, Tsugane S: Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study. Transl Psychiatry 2017 Sep 26;7(9):e1242 [28949340]
  5. Nagamine M, Noguchi H, Takahashi N, Kim Y, Matsuoka Y: Effect of cortisol diurnal rhythm on emotional memory in healthy young adults. Scientific Reports 2017 Aug 31;7(1): 10158 [28860606]
  6. Yamashita A, Noguchi H, Hamazaki K, Sato Y, Narisawa T, Kawashima Y, Usuki M, Nishi D, Yoshimasu H, Horikawa N, Matsuoka YJ: Serum polyunsaturated fatty acids and risk of psychiatric disorder after acute coronary syndrome: a prospective cohort study. J Affective Disorders August 2017 Aug 15;218: 306-312. [31421523]
  7. Nishi D, Su KP, Usuda K, Chang PC, Chiang YJ, Guu TW, Hamazaki K, Nakaya N, Sone T, Hashimoto K, Hamazaki T, Matsuoka YJ: Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: an open label pilot study. Nutritional Neuroscience 2017 Jul 28:1-9 [28752805]

2016

  1. Kawashima Y, Nishi D, Noguchi H, Usuki M, Yamashita A, Koido Y, Okubo Y, Matsuoka Y*: Post-traumatic Stress Symptoms and Burnout Among Medical Rescue Workers 4 Years after the Great East Japan Earthquake: A Longitudinal Study. Disaster Medicine and Public Health Preparedness 2016 Dec;10(6): 848-853 [27188495]
  2. Matsuoka YJ*, Hamazaki K, Nishi D, Hamazaki T: Change in blood levels of eicosapentaenoic acid and posttraumatic stress symptom: A secondary analysis of data from a placebo-controlled trial of omega-3 supplements J Affective Disorders 2016 Dec;10(6): 848-853 [27552592]
  3. Tanisho Y, Shigemura J, Kubota K, Tanigawa T, Bromet EJ, Takahashi S, Matsuoka Y, Nishi D, Nagamine M, Harada N, Tanichi M, Takahashi Y, Shimizu K, Nomura S, Yoshino A, Fukushima NEWS Project Collaborators: The longitudinal mental health impact of Fukushima nuclear disaster exposures and public criticism among power plant workers: the Fukushima NEWS Project study. Psychol Med 2016 Nov;46(15):3117-3125. [27534897]
  4. Yoshikawa E, Nishi D*, Matsuoka YJ: Association between frequency of fried food consumption and resilience to depression in Japanese company workers: A cross-sectional study. Lipids Health Dis. 2016 Sep 15;15(1):156 [27633655]
  5. Nishi D, Su K-P, Usuda K, Chiang Y-J, Guu T-W, Hamazaki K, Nakaya N, Sone T, Sano Y, Tachibana Y, Ito H, Isaka K, Hashimoto K, Hamazaki T, Matsuoka YJ: The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial. BMC Psychiatry 2016 Sep 15;16(1):321. [27630014]
  6. Nishi D, Kawashima Y, Noguchi H, Usuki M, Yamashita A, Koido Y, Matsuoka YJ*: Resilience, posttraumatic growth and work engagement among health care professionals after the Great East Japan Earthquake: A 4-year prospective follow-up study. J Occupational Health. 2016 Jul 22;58(4):347-53 [27265533]
  7. Yoshikawa E, Nishi D*, Matsuoka YJ: Association between regular physical exercise and depressive symptoms mediated through social support and resilience in Japanese company workers: A cross-sectional study. BMC Public Health 2016 Jul 22;58(4): 347-53 [27405459]
  8. Usuda K, Nishi D, Makino M, Tachimori H, Matsuoka Y, Sano Y, Konishi T, Takeshima T: Prevalence and related factors of common mental disorders during pregnancy in Japan: a cross-sectional study. Biopsychosocial Medicine 2016 Jul 12;16: 553 [27213012]